Treatment of cerebral edema

被引:79
作者
Rabinstein, AA [1 ]
机构
[1] Univ Miami, Sch Med, Dept Neurol, Miami, FL USA
关键词
cerebral edema; treatment; mannitol; hypertonic saline; intracranial pressure;
D O I
10.1097/01.nrl.0000186810.62736.f0
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Cerebral edema is a potentially devastating complication of various acute neurologic disorders. Its successful treatment may save lives and preserve neurologic function. Review, Summary: Different pathophysiological mechanisms are responsible for the formation of cytotoxic and vasogenic edema. Yet, these 2 types of edena often coexist and their treatment tends to overlap, with the exception of corticosteroids, which should be only used to ameliorate vasogenic edema. Currently available to control brain swelling include osmotic agents (with emphasis on mannitol and hypertonic saline solutions), corticosteroids, hyperventilation, sedation (propofol, barbiturates), neuromuscular paralysis, hypothermia, and surgical interventions. This article discusses the indications, advantages, and limitations of each treatment modality following an evidence-based approach. Conclusions: The therapy for brain edema remains largely empirical. More research aimed at enhancing our understanding of the pathophysiology of cerebral edema is needed to identify new and more effective forms of treatment.
引用
收藏
页码:59 / 73
页数:15
相关论文
共 167 条
[1]  
Abril V, 2003, NEW ENGL J MED, V348, P954
[2]   Slowing of peroxynitrite decomposition in the presence of mannitol and ethanol [J].
Alvarez, B ;
Ferrer-Sueta, G ;
Radi, R .
FREE RADICAL BIOLOGY AND MEDICINE, 1998, 24 (7-8) :1331-1337
[3]   Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator-treated patients [J].
Alvarez-Sabín, J ;
Molina, CA ;
Montaner, J ;
Arenillas, JF ;
Huertas, R ;
Ribo, M ;
Codina, A ;
Quintana, M .
STROKE, 2003, 34 (05) :1235-1240
[4]   Differences in blood-tumour-barrier leakage of human intracranial tumours: Quantitative monitoring of vasogenic oedema and its response to glucocorticoid treatment [J].
Andersen, C ;
Jensen, FT .
ACTA NEUROCHIRURGICA, 1998, 140 (09) :919-924
[5]   Serial determinations of cerebral water content by magnetic resonance imaging after an infusion of hypertonic saline [J].
Bacher, A ;
Wei, JN ;
Grafe, MR ;
Quast, MJ ;
Zornow, MH .
CRITICAL CARE MEDICINE, 1998, 26 (01) :108-114
[6]   Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome [J].
Baird, TA ;
Parsons, MW ;
Phanh, T ;
Butcher, KS ;
Desmond, PM ;
Tress, BM ;
Colman, PG ;
Chambers, BR ;
Davis, SM .
STROKE, 2003, 34 (09) :2208-2214
[7]   Randomized, controlled trial on the effect of a 20% mannitol solution and a 7.5% saline/6% dextran solution on increased intracranial pressure after brain injury [J].
Battison, C ;
Andrews, PJD ;
Graham, C ;
Petty, T .
CRITICAL CARE MEDICINE, 2005, 33 (01) :196-202
[8]   COMBINED HEMORRHAGIC-SHOCK AND HEAD-INJURY - EFFECTS OF HYPERTONIC SALINE (7.5-PERCENT) RESUSCITATION [J].
BATTISTELLA, FD ;
WISNER, DH .
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1991, 31 (02) :182-188
[9]   Dexamethasone as Treatment in Cerebrovascular Disease. 2. A Controlled Study in Acute Cerebral Infarction [J].
Bauer, Raymond B. ;
Tellez, Henry .
STROKE, 1973, 4 (04) :547-555
[10]  
BELL BA, 1987, LANCET, V1, P66